News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
phiRO’s 2023 impact factor is 3.4 – ESTRO
Photo from ESTRO/X
Jun 30, 2024, 10:20

phiRO’s 2023 impact factor is 3.4 – ESTRO

European Society for Radiotherapy and Oncology (ESTRO) posted on X:

“We’re pleased to announce phiRO’s 2023 impact factor of 3.4, making it a leading journal in medical physics. Achieved in just the 2nd year with an impact factor.”

Read further.
Source: ESTRO/X

cancer ESTRO medical physics OncoDaily Oncology phiRO
Special Coverage
Blog
Nov 13, 2024, 11:48
Indoor cooking with solid fuels can increase lung cancer risk - IASLC
Blog
Nov 13, 2024, 11:44
Registration for the AACR Annual Meeting 2025 is now open
Blog
Nov 13, 2024, 11:39
i4KIDS I i4KIDS-EUROPE - Ship2B Ventures Impact Forum
Blog
Nov 13, 2024, 11:34
Erika Hamilton: Inspired by the strength of the veteran patients and their commitment to continue fighting
Blog
Nov 13, 2024, 11:30
ABC Global Alliance - Learning more about brain metastases in breast cancer
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL